About Hexagon Bio: Hexagon Bio leverages a genomics-based platform and understanding of natural product evolution to develop next-generation medicines for human disease. Hexagon Bio 2018 - Present5 years Menlo Park Head Of Operations Stealth Startup 2016 - 20171 year Palo Alto Chief of Staff, Global Partnerships TED Conferences 2013 - 20163 years New York. choice merchant solutions Hexagon Bio 2018 - Present5 years Menlo Park Head Of Operations Stealth Startup 2016 - 20171 year Palo Alto Chief of Staff, Global Partnerships TED Conferences 2013 - 20163 years New York. ("Hexagon"), a biotechnology company turning nature's genomes into medicines, today announced that it has closed $47 million in. 15, 2020 /PRNewswire/ - Hexagon Bio, Inc. Type Private Status Active Founded 2016 HQ Menlo Park, CA, US | view all locations Website PARK, Calif., Sept. Its proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics. ![]() ![]() The funds will be used to further develop the company’s drug discovery platform and to build out its discovery team, CEO Maureen Hillenmeyer says. Hexagon Bio, a Menlo Park, California–based company trying to develop drugs from natural defense compounds secreted by fungi, has raised $47 million in series A financing.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |